Template:Percutaneous Coronary Intervention: Difference between revisions

	Percutaneous Coronary Intervention Microchapters
Home
Overview
Epidemiology and Demographics
Patient Information
Guideline Recommendations
CAD Revascularization:
Heart Team Approach to Revascularization Decisions
Left Main Coronary Artery Disease
Non-Left Main Coronary Artery Disease
Revascularization to Improve Symptoms
Dual Antiplatelet Therapy Compliance and Stent Thrombosis
Hybrid Coronary Revascularization
Pre-procedural Considerations:
Radiation Safety
Contrast-Induced Acute Kidney Injury
Anaphylactoid Reactions
Statin Treatment
Bleeding Risk
Role of Onsite Surgical Backup
Procedural Considerations:
Vascular Access
PCI in Specific Clinical Situations:
Asymptomatic Ischemia or CCS Class I or II Angina
CCS Class III Angina
Unstable Angina/Non–ST-Elevation Myocardial Infarction
ST-Elevation Myocardial Infarction:
General and Specific Considerations
Coronary Angiography Strategies in STEMI
Primary PCI of the Infarct Artery
Delayed or Elective PCI in patients with STEMI
Fibrinolytic-Ineligible Patients
Facilitated PCI
Rescue PCI
After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
Cardiogenic Shock
Prior Coronary Bypass Surgery
Revascularization Before Non-cardiac Surgery
Coronary Stents
Adjunctive Diagnostic Devices:
Fractional Flow Reserve
Intravascular Ultrasound
Adjunctive Therapeutic Devices:
Coronary Atherectomy
Thrombectomy
Laser Angioplasty
Cutting Balloon Angioplasty
Embolic Protection Devices
Percutaneous Hemodynamic Support Devices
Antiplatelet therapy:
Oral Antiplatelet Therapy
Intravenous Antiplatelet therapy:
STEMI
UA/NSTEMI
SIHD
Anticoagulant Therapy:
Parenteral Anticoagulants During PCI
Unfractionated Heparin
Enoxaparin
Bivalirudin and Argatroban
Fondaparinux
No-Reflow Pharmacological Therapies
PCI in Specific Anatomic Situations:
Chronic Total Occlusions
Saphenous Vein Grafts
Bifurcation Lesions
Aorto-Ostial Stenoses
Calcified Lesions
PCI in Specific Patient Populations:
Chronic Kidney Disease
Peri-procedural Myocardial Infarction Assessment
Vascular Closure Devices
Post-Procedural Considerations:
Post-procedural Antiplatelet Therapy:
Proton Pump Inhibitors and Antiplatelet Therapy
Clopidogrel Genetic Testing
Platelet Function Testing
Restenosis:
Exercise Testing
Cardiac Rehabilitation
Quality and Performance Considerations:
Quality and Performance
Certification and Maintenance of Certification
Operator and Institutional Competency and Volume
Percutaneous Coronary Intervention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Percutaneous Coronary Intervention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Percutaneous Coronary Intervention
CDC on Percutaneous Coronary Intervention
Percutaneous Coronary Intervention in the news
Blogs on Percutaneous Coronary Intervention
Directions to Hospitals Treating Percutaneous Coronary Intervention

VisualWikitext

Template:Percutaneous Coronary Intervention: Difference between revisions

Revision as of 20:34, 18 October 2012

Navigation menu

@@ Line 10: / Line 10: @@
 |- bgcolor="LightCoral"
 !
-[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines|Home]]
+[[Percutaneous coronary intervention: basic principles and guidelines|Home]]
 |-
 !
@@ Line 46: / Line 46: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) heart team approach to revascularization decisions|Heart Team Approach to Revascularization Decisions]]
+::[[Percutaneous coronary intervention heart team approach to revascularization decisions|Heart Team Approach to Revascularization Decisions]]
 |-
 !
@@ Line 52: / Line 52: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) left main coronary artery disease|Left Main Coronary Artery Disease]]
+::[[Percutaneous coronary intervention left main coronary artery disease|Left Main Coronary Artery Disease]]
 |-
 !
@@ Line 58: / Line 58: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]]
+::[[Percutaneous coronary intervention non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]]
 |-
 !
@@ Line 64: / Line 64: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) revascularization to improve symptoms|Revascularization to Improve Symptoms]]
+::[[Percutaneous coronary intervention revascularization to improve symptoms|Revascularization to Improve Symptoms]]
 |-
 !
@@ Line 70: / Line 70: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]]
+::[[Percutaneous coronary intervention dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]]
 |-
 !
@@ Line 76: / Line 76: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) hybrid coronary revascularization|Hybrid Coronary Revascularization]]
+::[[Percutaneous coronary intervention hybrid coronary revascularization|Hybrid Coronary Revascularization]]
 |-
 !
@@ Line 88: / Line 88: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) radiation safety|Radiation Safety]]
+::[[Percutaneous coronary intervention radiation safety|Radiation Safety]]
 |-
 !
@@ Line 94: / Line 94: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]]
+::[[Percutaneous coronary intervention contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]]
 |-
 !
@@ Line 100: / Line 100: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) anaphylactoid reactions|Anaphylactoid Reactions]]
+::[[Percutaneous coronary intervention anaphylactoid reactions|Anaphylactoid Reactions]]
 |-
 !
@@ Line 106: / Line 106: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) statin treatment|Statin Treatment]]
+::[[Percutaneous coronary intervention statin treatment|Statin Treatment]]
 |-
 !
@@ Line 112: / Line 112: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) bleeding risk|Bleeding Risk]]
+::[[Percutaneous coronary intervention bleeding risk|Bleeding Risk]]
 |-
 !
@@ Line 118: / Line 118: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) role of onsite surgical backup|Role of Onsite Surgical Backup]]
+::[[Percutaneous coronary intervention role of onsite surgical backup|Role of Onsite Surgical Backup]]
 |-
 !
@@ Line 130: / Line 130: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) vascular access|Vascular Access]]
+::[[Percutaneous coronary intervention vascular access|Vascular Access]]
 |-
 !
@@ Line 142: / Line 142: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) asymptomatic ischemia or CCS class I or II angina|Asymptomatic Ischemia or CCS Class I or II Angina]]
+::[[Percutaneous coronary intervention asymptomatic ischemia or CCS class I or II angina|Asymptomatic Ischemia or CCS Class I or II Angina]]
 |-
 !
@@ Line 148: / Line 148: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) CCS class III angina|CCS Class III Angina]]
+::[[Percutaneous coronary intervention CCS class III angina|CCS Class III Angina]]
 |-
 !
@@ Line 154: / Line 154: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) unstable Angina/non-ST-elevation myocardial infarction|Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
+::[[Percutaneous coronary intervention unstable Angina/non-ST-elevation myocardial infarction|Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
 |-
 !
@@ Line 166: / Line 166: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) general and specific considerations|General and Specific Considerations]]
+:::[[Percutaneous coronary intervention general and specific considerations|General and Specific Considerations]]
 |-
 !
@@ Line 172: / Line 172: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) coronary angiography strategies in STEMI|Coronary Angiography Strategies in STEMI]]
+:::[[Percutaneous coronary intervention coronary angiography strategies in STEMI|Coronary Angiography Strategies in STEMI]]
 |-
 !
@@ Line 178: / Line 178: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) primary PCI of the infarct artery|Primary PCI of the Infarct Artery]]
+:::[[Percutaneous coronary intervention primary PCI of the infarct artery|Primary PCI of the Infarct Artery]]
 |-
 !
@@ Line 184: / Line 184: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) delayed or elective PCI in patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
+:::[[Percutaneous coronary intervention delayed or elective PCI in patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
 |-
 !
@@ Line 190: / Line 190: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) fibrinolytic-ineligible patients|Fibrinolytic-Ineligible Patients]]
+:::[[Percutaneous coronary intervention fibrinolytic-ineligible patients|Fibrinolytic-Ineligible Patients]]
 |-
 !
@@ Line 196: / Line 196: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) facilitated PCI|Facilitated PCI]]
+:::[[Percutaneous coronary intervention facilitated PCI|Facilitated PCI]]
 |-
 !
@@ Line 202: / Line 202: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) rescue PCI (PCI after failed fibrinolysis)|Rescue PCI]]
+:::[[Percutaneous coronary intervention rescue PCI (PCI after failed fibrinolysis)|Rescue PCI]]
 |-
 !
@@ Line 208: / Line 208: @@
 |- bgcolor="PaleTurquoise"
 !
-:::[[Percutaneous Coronary Intervention (PCI) after successful fibrinolysis or for patients not undergoing primary reperfusion|After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]]
+:::[[Percutaneous coronary intervention after successful fibrinolysis or for patients not undergoing primary reperfusion|After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]]
 |-
 !
@@ Line 214: / Line 214: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) Cardiogenic shock|Cardiogenic Shock]]
+:[[Percutaneous coronary intervention Cardiogenic shock|Cardiogenic Shock]]
 |-
 !
@@ Line 220: / Line 220: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) prior coronary bypass surgery|Prior Coronary Bypass Surgery]]
+:[[Percutaneous coronary intervention prior coronary bypass surgery|Prior Coronary Bypass Surgery]]
 |-
 !
@@ Line 226: / Line 226: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) revascularization before non-cardiac surgery|Revascularization Before Non-cardiac Surgery]]
+:[[Percutaneous coronary intervention revascularization before non-cardiac surgery|Revascularization Before Non-cardiac Surgery]]
 |-
 !
@@ Line 232: / Line 232: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) coronary stents|Coronary Stents]]
+:[[Percutaneous coronary intervention coronary stents|Coronary Stents]]
 |-
 !
@@ Line 244: / Line 244: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) fractional flow reserve|Fractional Flow Reserve]]
+::[[Percutaneous coronary intervention fractional flow reserve|Fractional Flow Reserve]]
 |-
 !
@@ Line 250: / Line 250: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) intravascular ultrasound|Intravascular Ultrasound]]
+::[[Percutaneous coronary intervention intravascular ultrasound|Intravascular Ultrasound]]
 |-
 !
@@ Line 262: / Line 262: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) coronary atherectomy|Coronary Atherectomy]]
+::[[Percutaneous coronary intervention coronary atherectomy|Coronary Atherectomy]]
 |-
 !
@@ Line 268: / Line 268: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) thrombectomy|Thrombectomy]]
+::[[Percutaneous coronary intervention thrombectomy|Thrombectomy]]
 |-
 !
@@ Line 274: / Line 274: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) laser angioplasty|Laser Angioplasty]]
+::[[Percutaneous coronary intervention laser angioplasty|Laser Angioplasty]]
 |-
 !
@@ Line 280: / Line 280: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) cutting balloon angioplasty|Cutting Balloon Angioplasty]]
+::[[Percutaneous coronary intervention cutting balloon angioplasty|Cutting Balloon Angioplasty]]
 |-
 !
@@ Line 286: / Line 286: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) embolic protection devices|Embolic Protection Devices]]
+::[[Percutaneous coronary intervention embolic protection devices|Embolic Protection Devices]]
 |-
 !
@@ Line 292: / Line 292: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) percutaneous hemodynamic support devices|Percutaneous Hemodynamic Support Devices]]
+:[[Percutaneous coronary intervention percutaneous hemodynamic support devices|Percutaneous Hemodynamic Support Devices]]
 |-
 !
@@ Line 304: / Line 304: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) oral antiplatelet therapy|Oral Antiplatelet Therapy]]
+::[[Percutaneous coronary intervention oral antiplatelet therapy|Oral Antiplatelet Therapy]]
 |-
 !
@@ Line 316: / Line 316: @@
 |- bgcolor="PaleTurquoise"
 !
-::::[[Percutaneous Coronary Intervention (PCI) ST-elevation myocardial infarction (STEMI)|STEMI]]
+::::[[Percutaneous coronary intervention ST-elevation myocardial infarction (STEMI)|STEMI]]
 |-
 !
@@ Line 322: / Line 322: @@
 |- bgcolor="PaleTurquoise"
 !
-::::[[Percutaneous Coronary Intervention (PCI) unstable angina / non-ST elevation myocardial infarction (UA/NSTEMI)|UA/NSTEMI]]
+::::[[Percutaneous coronary intervention unstable angina / non-ST elevation myocardial infarction (UA/NSTEMI)|UA/NSTEMI]]
 |-
 !
@@ Line 328: / Line 328: @@
 |- bgcolor="PaleTurquoise"
 !
-::::[[Percutaneous Coronary Intervention (PCI) sudden ischemia heart disease (SIHD)|SIHD]]
+::::[[Percutaneous coronary intervention sudden ischemia heart disease (SIHD)|SIHD]]
 |-
 !
@@ Line 340: / Line 340: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) use of parenteral anticoagulants during PCI|Parenteral Anticoagulants During PCI]]
+::[[Percutaneous coronary intervention use of parenteral anticoagulants during PCI|Parenteral Anticoagulants During PCI]]
 |-
 !
@@ Line 346: / Line 346: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) unfractionated heparin|Unfractionated Heparin]]
+::[[Percutaneous coronary intervention unfractionated heparin|Unfractionated Heparin]]
 |-
 !
@@ Line 352: / Line 352: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) enoxaparin|Enoxaparin]]
+::[[Percutaneous coronary intervention enoxaparin|Enoxaparin]]
 |-
 !
@@ Line 358: / Line 358: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) bivalirudin and argatoban|Bivalirudin and Argatroban]]
+::[[Percutaneous coronary intervention bivalirudin and argatoban|Bivalirudin and Argatroban]]
 |-
 !
@@ Line 364: / Line 364: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) fondaparinux|Fondaparinux]]
+::[[Percutaneous coronary intervention fondaparinux|Fondaparinux]]
 |-
 !
@@ Line 370: / Line 370: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) no-reflow pharmacological therapies|No-Reflow Pharmacological Therapies]]
+::[[Percutaneous coronary intervention no-reflow pharmacological therapies|No-Reflow Pharmacological Therapies]]
 |-
 !
@@ Line 382: / Line 382: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) chronic total occlusions|Chronic Total Occlusions]]
+::[[Percutaneous coronary intervention chronic total occlusions|Chronic Total Occlusions]]
 |-
 !
@@ Line 388: / Line 388: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) saphenous vein grafts|Saphenous Vein Grafts]]
+::[[Percutaneous coronary intervention saphenous vein grafts|Saphenous Vein Grafts]]
 |-
 !
@@ Line 394: / Line 394: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) bifurcation lesions|Bifurcation Lesions]]
+::[[Percutaneous coronary intervention bifurcation lesions|Bifurcation Lesions]]
 |-
 !
@@ Line 400: / Line 400: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) aorto-ostial stenoses|Aorto-Ostial Stenoses]]
+::[[Percutaneous coronary intervention aorto-ostial stenoses|Aorto-Ostial Stenoses]]
 |-
 !
@@ Line 406: / Line 406: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) calcified lesions|Calcified Lesions]]
+::[[Percutaneous coronary intervention calcified lesions|Calcified Lesions]]
 |-
 !
@@ Line 418: / Line 418: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) chronic kidney disease|Chronic Kidney Disease]]
+::[[Percutaneous coronary intervention chronic kidney disease|Chronic Kidney Disease]]
 |-
 !
@@ Line 424: / Line 424: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) peri-procedural myocardial infarction assessment|Peri-procedural Myocardial Infarction Assessment]]
+:[[Percutaneous coronary intervention peri-procedural myocardial infarction assessment|Peri-procedural Myocardial Infarction Assessment]]
 |-
 !
@@ Line 430: / Line 430: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) vascular closure devices|Vascular Closure Devices]]
+:[[Percutaneous coronary intervention vascular closure devices|Vascular Closure Devices]]
 |-
 !
@@ Line 442: / Line 442: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) post-procedural antiplatelet therapy|Post-procedural Antiplatelet Therapy:]]
+:[[Percutaneous coronary intervention post-procedural antiplatelet therapy|Post-procedural Antiplatelet Therapy:]]
 |-
 !
@@ Line 448: / Line 448: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) proton pump inhibitors and anti-platelet therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]
+::[[Percutaneous coronary intervention proton pump inhibitors and anti-platelet therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]
 |-
 !
@@ Line 454: / Line 454: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) clopidogrel genetic testing|Clopidogrel Genetic Testing]]
+::[[Percutaneous coronary intervention clopidogrel genetic testing|Clopidogrel Genetic Testing]]
 |-
 !
@@ Line 460: / Line 460: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) platelet function testing|Platelet Function Testing]]
+::[[Percutaneous coronary intervention platelet function testing|Platelet Function Testing]]
 |-
 !
@@ Line 466: / Line 466: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) restenosis|Restenosis:]]
+:[[Percutaneous coronary intervention restenosis|Restenosis:]]
 |-
 !
@@ Line 472: / Line 472: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) exercise testing|Exercise Testing]]
+::[[Percutaneous coronary intervention exercise testing|Exercise Testing]]
 |-
 !
@@ Line 478: / Line 478: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) cardiac rehabilitation|Cardiac Rehabilitation]]
+::[[Percutaneous coronary intervention cardiac rehabilitation|Cardiac Rehabilitation]]
 |-
 !
@@ Line 490: / Line 490: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) quality and performance|Quality and Performance]]
+:[[Percutaneous coronary intervention quality and performance|Quality and Performance]]
 |-
 !
@@ Line 496: / Line 496: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) certification and maintenance of certification|Certification and Maintenance of Certification]]
+:[[Percutaneous coronary intervention certification and maintenance of certification|Certification and Maintenance of Certification]]
 |-
 !
@@ Line 502: / Line 502: @@
 |- bgcolor="PaleTurquoise"
 !
-:[[Percutaneous Coronary Intervention (PCI) operator and institutional competency and volume|Operator and Institutional Competency and Volume]]
+:[[Percutaneous coronary intervention operator and institutional competency and volume|Operator and Institutional Competency and Volume]]
 |-
 !